{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,10]],"date-time":"2026-06-10T05:51:26Z","timestamp":1781070686448,"version":"3.54.1"},"reference-count":41,"publisher":"Ovid Technologies (Wolters Kluwer Health)","issue":"28","license":[{"start":{"date-parts":[[2024,7,12]],"date-time":"2024-07-12T00:00:00Z","timestamp":1720742400000},"content-version":"unspecified","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc\/4.0\/"}],"content-domain":{"domain":["lww.com","ovid.com"],"crossmark-restriction":true},"short-container-title":[],"published-print":{"date-parts":[[2024,7,12]]},"abstract":"<jats:p>\n                    Non-alcoholic fatty liver disease (NAFLD) encompasses a broad spectrum of diseases and stands as the second most prevalent liver disorder in the 21st century. Advanced hepatic fibrosis (AHF) is a crucial indicator of the progression of NAFLD. Selenium (Se) is an indispensable trace element for human physiology; however, excessive intake can lead to poisoning and detrimental effects. Notably, males exhibit significantly higher serum Se levels compared to females. To investigate the correlation between serum Se levels and the prevalence of NAFLD and AHF across different genders. Utilizing data from the National Health and Nutrition Examination Survey (NHANES) 2017\u20132020, 7271 participants were included. Through descriptive analysis, multivariable logistic regression, subgroup analysis, interaction, and restricted cubic spline regression analysis, the relationship between serum Se levels and the prevalence of NAFLD and AHF was investigated. serum Se levels were significantly higher in both male and female NAFLD groups compared to the non-NAFLD groups (Males: 187.570 vs 183.300, Z\u2005=\u2005\u221216.169,\n                    <jats:italic toggle=\"yes\">P<\/jats:italic>\n                    \u2005&lt;\u2005.001; Females: 184.780 vs 180.130, Z\u2005=\u2005\u22124.102,\n                    <jats:italic toggle=\"yes\">P<\/jats:italic>\n                    \u2005&lt;\u2005.001). After adjusting for confounders, an increase in one quartile of serum Se was associated with a 17.60% increase in NAFLD prevalence in males (OR, 1.176; 95% CI: 1.052\u20131.315) and a 38.50% decrease in AHF prevalence (OR, 0.615; 95% CI: 0.479\u20130.789). In females, each quartile increase in serum Se was associated with a 29.10% increase in NAFLD prevalence (OR,1.291;95%CI: 1.155\u20131.442) and a 51.60% decrease in AHF prevalence (OR, 0.484; 95% CI: 0.344\u20130.682). serum Se levels are positively correlated with the prevalence of NAFLD and negatively correlated with the prevalence of AHF in both males and females.\n                  <\/jats:p>","DOI":"10.1097\/md.0000000000038845","type":"journal-article","created":{"date-parts":[[2024,7,12]],"date-time":"2024-07-12T15:08:43Z","timestamp":1720796923000},"page":"e38845","update-policy":"https:\/\/doi.org\/10.1097\/lww.0000000000001000","source":"Crossref","is-referenced-by-count":3,"title":["Association between serum selenium and non-alcoholic fatty liver disease: Results from NHANES: An observational study"],"prefix":"10.1097","volume":"103","author":[{"given":"Yajie","family":"Liu","sequence":"first","affiliation":[{"name":"Department of Spleen, Stomach, Liver and Gallbladder Diseases, The First Affiliated Hospital of Henan University of Traditional Chinese Medicine, Zhengzhou, China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0009-0001-6018-4070","authenticated-orcid":false,"given":"Ruilin","family":"Wang","sequence":"additional","affiliation":[{"name":"Department of Traditional Chinese Medicine and Liver Diseases, Fifth Medical Center, PLA General Hospital, Beijing, China."}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"276","reference":[{"key":"R1-20260204","doi-asserted-by":"crossref","first-page":"1388","DOI":"10.1016\/j.jhep.2015.11.004","article-title":"EASL-EASD-EASO Clinical Practice Guidelines for the management of non-alcoholic fatty liver disease.","volume":"64","year":"2016","journal-title":"J Hepatol"},{"key":"R2-20260204","doi-asserted-by":"crossref","first-page":"73","DOI":"10.1002\/hep.28431","article-title":"Global epidemiology of nonalcoholic fatty liver disease-meta-analytic assessment of prevalence, incidence, and outcomes.","volume":"64","author":"Younossi","year":"2016","journal-title":"Hepatology (Baltimore, Md.)"},{"key":"R3-20260204","doi-asserted-by":"crossref","first-page":"288","DOI":"10.1038\/s41574-019-0176-8","article-title":"Obesity: global epidemiology and pathogenesis.","volume":"15","author":"Bl\u00fcher","year":"2019","journal-title":"Nat Rev Endocrinol"},{"key":"R4-20260204","doi-asserted-by":"crossref","first-page":"20","DOI":"10.1016\/S2468-1253(22)00317-X","article-title":"Global prevalence of non-alcoholic fatty liver disease and non-alcoholic steatohepatitis in the overweight and obese population: a systematic review and meta-analysis.","volume":"8","author":"Quek","year":"2023","journal-title":"Lancet Gastroenterol Hepatol"},{"key":"R5-20260204","doi-asserted-by":"crossref","first-page":"1577","DOI":"10.1002\/hep.28785","article-title":"The economic and clinical burden of nonalcoholic fatty liver disease in the United States and Europe.","volume":"64","author":"Younossi","year":"2016","journal-title":"Hepatology (Baltimore, Md.)"},{"key":"R6-20260204","doi-asserted-by":"crossref","first-page":"2063","DOI":"10.1056\/NEJMra1503519","article-title":"Cause, pathogenesis, and treatment of nonalcoholic steatohepatitis.","volume":"377","author":"Diehl","year":"2017","journal-title":"N Engl J Med"},{"key":"R7-20260204","doi-asserted-by":"crossref","first-page":"1006","DOI":"10.1136\/gutjnl-2021-324243","article-title":"Diagnostic accuracy of non-invasive tests for advanced fibrosis in patients with NAFLD: an individual patient data meta-analysis.","volume":"71","author":"M\u00f3zes","year":"2022","journal-title":"Gut"},{"key":"R8-20260204","doi-asserted-by":"crossref","first-page":"1149","DOI":"10.1111\/apt.15679","article-title":"Nonalcoholic fatty liver disease progression rates to cirrhosis and progression of cirrhosis to decompensation and mortality: a real-world analysis of Medicare data.","volume":"51","author":"Loomba","year":"2020","journal-title":"Aliment Pharmacol Ther"},{"key":"R9-20260204","doi-asserted-by":"crossref","first-page":"1256","DOI":"10.1016\/S0140-6736(11)61452-9","article-title":"Selenium and human health.","volume":"379","author":"Rayman","year":"2012","journal-title":"Lancet (London, England)"},{"key":"R10-20260204","doi-asserted-by":"crossref","first-page":"182","DOI":"10.1016\/j.freeradbiomed.2018.03.037","article-title":"Relationship between selenoprotein P and selenocysteine lyase: Insights into selenium metabolism.","volume":"127","author":"Seale","year":"2018","journal-title":"Free Radic Biol Med"},{"key":"R11-20260204","doi-asserted-by":"crossref","first-page":"158","DOI":"10.1016\/j.lfs.2013.10.008","article-title":"Serum selenium levels and oxidative balance as differential markers in hepatic damage caused by alcohol.","volume":"94","author":"Rua","year":"2014","journal-title":"Life Sci"},{"key":"R12-20260204","doi-asserted-by":"crossref","first-page":"91","DOI":"10.1007\/s002040050040","article-title":"Toxicity and chemical form of selenium in the liver of mice orally administered selenocystine for 90 days.","volume":"68","author":"Hasegawa","year":"1994","journal-title":"Arch Toxicol"},{"key":"R13-20260204","doi-asserted-by":"crossref","first-page":"155","DOI":"10.1016\/j.chemosphere.2007.06.038","article-title":"Trace element levels in adults from the west coast of Canada and associations with age, gender, diet, activities, and levels of other trace elements.","volume":"70","author":"Clark","year":"2007","journal-title":"Chemosphere"},{"key":"R14-20260204","doi-asserted-by":"crossref","first-page":"1175","DOI":"10.1001\/jama.2020.2298","article-title":"Nonalcoholic steatohepatitis: a review.","volume":"323","author":"Sheka","year":"2020","journal-title":"JAMA"},{"key":"R15-20260204","doi-asserted-by":"crossref","first-page":"1723","DOI":"10.1001\/jama.2019.2276","article-title":"Prevalence of alcoholic fatty liver disease among adults in the United States, 2001-2016.","volume":"321","author":"Wong","year":"2019","journal-title":"JAMA"},{"key":"R16-20260204","doi-asserted-by":"crossref","first-page":"911","DOI":"10.1111\/j.1478-3231.2012.02820.x","article-title":"Non-invasive diagnosis of liver steatosis using controlled attenuation parameter (CAP) and transient elastography.","volume":"32","author":"De L\u00e9dinghen","year":"2012","journal-title":"Liver Int"},{"key":"R17-20260204","doi-asserted-by":"crossref","first-page":"1264","DOI":"10.1053\/j.gastro.2018.12.036","article-title":"Noninvasive assessment of liver disease in patients with nonalcoholic Fatty liver disease.","volume":"156","author":"Castera","year":"2019","journal-title":"Gastroenterology"},{"key":"R18-20260204","doi-asserted-by":"crossref","first-page":"1797","DOI":"10.1097\/HEP.0000000000000323","article-title":"AASLD Practice Guidance on the clinical assessment and management of nonalcoholic fatty liver disease.","volume":"77","author":"Rinella","year":"2023","journal-title":"Hepatology (Baltimore, Md.)"},{"key":"R19-20260204","doi-asserted-by":"crossref","first-page":"836357","DOI":"10.3389\/fpubh.2022.836357","article-title":"Association between blood lead level with high blood pressure in US (NHANES 1999\u20132018).","volume":"10","author":"Huang","year":"2022","journal-title":"Front Public Health"},{"key":"R20-20260204","doi-asserted-by":"crossref","first-page":"378","DOI":"10.1016\/j.jad.2022.11.088","article-title":"Associations of serum zinc, copper, and selenium with sleep disorders in the American adults: data from NHANES 2011-2016.","volume":"323","author":"Deng","year":"2023","journal-title":"J Affect Disord"},{"key":"R21-20260204","doi-asserted-by":"crossref","first-page":"277","DOI":"10.1016\/j.jhep.2023.04.002","article-title":"Using the ELF test, FIB-4 and NAFLD fibrosis score to screen the population for liver disease.","volume":"79","author":"Kjaergaard","year":"2023","journal-title":"J Hepatol"},{"key":"R22-20260204","doi-asserted-by":"crossref","first-page":"1083032","DOI":"10.3389\/fendo.2023.1083032","article-title":"Prediction of MAFLD and NAFLD using different screening indexes: a cross-sectional study in U.S. adults.","volume":"14","author":"Peng","year":"2023","journal-title":"Front Endocrinol"},{"key":"R23-20260204","doi-asserted-by":"crossref","first-page":"103","DOI":"10.1080\/07315724.2019.1613271","article-title":"Association between dietary selenium intake and the prevalence of nonalcoholic fatty liver disease: a cross-sectional study.","volume":"39","author":"Wu","year":"2020","journal-title":"J Am Coll Nutr"},{"key":"R24-20260204","doi-asserted-by":"crossref","first-page":"113647","DOI":"10.1016\/j.envres.2022.113647","article-title":"Association of blood manganese, selenium with steatosis, fibrosis in the National Health and Nutrition Examination Survey, 2017-18.","volume":"213","author":"Spaur","year":"2022","journal-title":"Environ Res"},{"key":"R25-20260204","doi-asserted-by":"crossref","first-page":"2259","DOI":"10.1080\/07853890.2022.2110277","article-title":"The association between non-alcoholic fatty liver disease (NAFLD) and advanced fibrosis with blood selenium level based on the NHANES 2017-2018.","volume":"54","author":"Liu","year":"2022","journal-title":"Ann Med"},{"key":"R26-20260204","doi-asserted-by":"crossref","first-page":"111190","DOI":"10.1016\/j.envres.2021.111190","article-title":"Serum selenium and non-alcoholic fatty liver disease (NAFLD) in U.S. adults: National Health and Nutrition Examination Survey (NHANES) 2011\u20132016.","volume":"197","author":"Wang","year":"2021","journal-title":"Environ Res"},{"key":"R27-20260204","doi-asserted-by":"crossref","first-page":"103","DOI":"10.1080\/07315724.2019.1613271","article-title":"Association between dietary selenium intake and the prevalence of nonalcoholic Fatty liver disease: a cross-sectional study.","volume":"39","author":"Wu","year":"2020","journal-title":"J Am Coll Nutr"},{"key":"R28-20260204","doi-asserted-by":"crossref","first-page":"2328","DOI":"10.3945\/jn.108.089482","article-title":"Redox regulation of protein tyrosine phosphatase 1B by manipulation of dietary selenium affects the triglyceride concentration in rat liver.","volume":"138","author":"Mueller","year":"2008","journal-title":"J Nutr"},{"key":"R29-20260204","doi-asserted-by":"crossref","first-page":"235","DOI":"10.1016\/j.jnutbio.2008.02.007","article-title":"Regulation of the insulin antagonistic protein tyrosine phosphatase 1B by dietary Se studied in growing rats.","volume":"20","author":"Mueller","year":"2009","journal-title":"J Nutr Biochem"},{"key":"R30-20260204","doi-asserted-by":"crossref","first-page":"e0303140","DOI":"10.1371\/journal.pone.0303140","article-title":"Selenium intake in relation to all-cause and cardiovascular mortality in individuals with nonalcoholic fatty liver disease: a nationwide study in nutrition.","volume":"19","author":"Dong","year":"2024","journal-title":"PLoS One"},{"key":"R31-20260204","doi-asserted-by":"crossref","first-page":"61","DOI":"10.1007\/s42000-019-00127-3","article-title":"Selenium and selenoprotein P in nonalcoholic fatty liver disease.","volume":"19","author":"Polyzos","year":"2020","journal-title":"Hormones (Athens, Greece)"},{"key":"R32-20260204","doi-asserted-by":"crossref","first-page":"830","DOI":"10.1136\/gutjnl-2014-306842","article-title":"Pathobiology of liver fibrosis: a translational success story.","volume":"64","author":"Lee","year":"2015","journal-title":"Gut"},{"key":"R33-20260204","doi-asserted-by":"crossref","first-page":"739","DOI":"10.1152\/physrev.00039.2013","article-title":"Selenoproteins: molecular pathways and physiological roles.","volume":"94","author":"Labunskyy","year":"2014","journal-title":"Physiol Rev"},{"key":"R34-20260204","doi-asserted-by":"crossref","first-page":"5308","DOI":"10.3390\/nu14245308","article-title":"Selenium status: its interactions with dietary mercury exposure and implications in human health.","volume":"14","author":"Tinggi","year":"2022","journal-title":"Nutrients"},{"key":"R35-20260204","doi-asserted-by":"crossref","first-page":"37288","DOI":"10.1038\/srep37288","article-title":"Plasma selenium levels and nonalcoholic fatty liver disease in Chinese adults: a cross-sectional analysis.","volume":"6","author":"Yang","year":"2016","journal-title":"Sci Rep"},{"key":"R36-20260204","doi-asserted-by":"crossref","first-page":"101547","DOI":"10.1016\/j.eclinm.2022.101547","article-title":"Accuracy of controlled attenuation parameter (CAP) and liver stiffness measurement (LSM) for assessing steatosis and fibrosis in non-alcoholic fatty liver disease: a systematic review and meta-analysis.","volume":"51","author":"Cao","year":"2022","journal-title":"EClinicalMedicine"},{"key":"R37-20260204","doi-asserted-by":"crossref","first-page":"925690","DOI":"10.3389\/fimmu.2022.925690","article-title":"Association between SII and hepatic steatosis and liver fibrosis: a population-based study.","volume":"13","author":"Xie","year":"2022","journal-title":"Front Immunol"},{"key":"R38-20260204","doi-asserted-by":"crossref","first-page":"65","DOI":"10.1111\/apt.13012","article-title":"Fatty liver indices in the multiethnic United States National Health and Nutrition Examination Survey.","volume":"41","author":"Ruhl","year":"2015","journal-title":"Aliment Pharmacol Ther"},{"key":"R39-20260204","doi-asserted-by":"crossref","first-page":"4574","DOI":"10.2174\/1381612825666190117102111","article-title":"Diagnosis of non-alcoholic fatty liver disease (NAFLD): current concepts.","volume":"24","author":"Papatheodoridi","year":"2018","journal-title":"Curr Pharm Des"},{"key":"R40-20260204","doi-asserted-by":"crossref","first-page":"464","DOI":"10.1007\/s40572-018-0213-0","article-title":"Environmental selenium and human health: an update.","volume":"5","author":"Vinceti","year":"2018","journal-title":"Curr Environ Health Rep"},{"key":"R41-20260204","doi-asserted-by":"crossref","first-page":"13","DOI":"10.1016\/S0946-672X(03)80040-8","article-title":"Sex, age, geographical location, smoking, and alcohol consumption influence serum selenium concentrations in the USA: third national health and nutrition examination survey, 1988\u20131994.","volume":"17","author":"Kafai","year":"2003","journal-title":"J Trace Elements Med Biol"}],"container-title":["Medicine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/journals.lww.com\/10.1097\/MD.0000000000038845","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,2,4]],"date-time":"2026-02-04T14:01:22Z","timestamp":1770213682000},"score":1,"resource":{"primary":{"URL":"https:\/\/journals.lww.com\/10.1097\/MD.0000000000038845"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,7,12]]},"references-count":41,"journal-issue":{"issue":"28","published-print":{"date-parts":[[2024]]}},"URL":"https:\/\/doi.org\/10.1097\/md.0000000000038845","relation":{},"ISSN":["0025-7974","1536-5964"],"issn-type":[{"value":"0025-7974","type":"print"},{"value":"1536-5964","type":"electronic"}],"subject":[],"published":{"date-parts":[[2024,7,12]]}}}